FLS
53
-15
GE
72
5
AMT
37
-2
FRT
58
-2
WMB
48
-4
EOG
49
-3
HOG
35
-3
FTI
82
-2
AMP
73
-3
SLB
49
-4
SIG
49
-6
PCAR
65
-3
C
79
-2
CPB
39
2
URI
46
-4
ICE
67
-2
STX
67
-7
BMY
74
5
EQIX
50
-3
HIG
56
-2
FLS
53
-15
GE
72
5
AMT
37
-2
FRT
58
-2
WMB
48
-4
EOG
49
-3
HOG
35
-3
FTI
82
-2
AMP
73
-3
SLB
49
-4
SIG
49
-6
PCAR
65
-3
C
79
-2
CPB
39
2
URI
46
-4
ICE
67
-2
STX
67
-7
BMY
74
5
EQIX
50
-3
HIG
56
-2
Financhill
Back

Calvert US Mid-Cap Core Responsible Index ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Buy
54

CVMC
Calvert US Mid-Cap Core Responsible Index ETF

Last Price:
$65.72
Seasonality Move:
2.92%
Buy
67

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$113.50
Seasonality Move:
-9.01%
Buy
54
Calvert US Mid-Cap Core Responsible Index ETF (CVMC) is a Buy

Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?

  • The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $65.00. The Score for CVMC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • CVMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CVMC Stock Price Chart

What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?

  • The Calvert US Mid-Cap Core Responsible Index ETF share price today is $65.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVMC is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

CVMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 58.57 Buy
Chaikin Money Flow: -2565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.4 - 64.76) Buy
Bollinger Bands (100): (62.19 - 64.07) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

CVMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.7 Buy
20-day SMA: 63.59 Buy
50-day SMA: 63.46 Buy
200-day SMA: 60.59 Buy
8-day EMA: 64.72 Buy
20-day EMA: 64.08 Buy
50-day EMA: 63.54 Buy
200-day EMA: 61.63 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):